DE60122477D1 - Verfahren zur erhöhung der darmabsorption von fettlöslichen vitaminen bei postmenopausalen frauen und in tieren - Google Patents

Verfahren zur erhöhung der darmabsorption von fettlöslichen vitaminen bei postmenopausalen frauen und in tieren

Info

Publication number
DE60122477D1
DE60122477D1 DE60122477T DE60122477T DE60122477D1 DE 60122477 D1 DE60122477 D1 DE 60122477D1 DE 60122477 T DE60122477 T DE 60122477T DE 60122477 T DE60122477 T DE 60122477T DE 60122477 D1 DE60122477 D1 DE 60122477D1
Authority
DE
Germany
Prior art keywords
darm
fat
animals
absorption
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122477T
Other languages
English (en)
Other versions
DE60122477T2 (de
Inventor
Lynn Gross
Kevin Owen
I Koo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Kansas State University
Hills Pet Nutrition Inc
Original Assignee
Lonza AG
Kansas State University
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26884060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60122477(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza AG, Kansas State University, Hills Pet Nutrition Inc filed Critical Lonza AG
Publication of DE60122477D1 publication Critical patent/DE60122477D1/de
Application granted granted Critical
Publication of DE60122477T2 publication Critical patent/DE60122477T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60122477T 2000-03-10 2001-03-06 Verfahren zur erhöhung der darmabsorption von fettlöslichen vitaminen bei postmenopausalen frauen und in tieren Expired - Lifetime DE60122477T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18841900P 2000-03-10 2000-03-10
US188419P 2000-03-10
US797305 2001-03-01
US09/797,305 US6476010B2 (en) 2000-03-10 2001-03-01 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
PCT/US2001/007303 WO2001068075A2 (en) 2000-03-10 2001-03-06 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals

Publications (2)

Publication Number Publication Date
DE60122477D1 true DE60122477D1 (de) 2006-10-05
DE60122477T2 DE60122477T2 (de) 2007-05-24

Family

ID=26884060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122477T Expired - Lifetime DE60122477T2 (de) 2000-03-10 2001-03-06 Verfahren zur erhöhung der darmabsorption von fettlöslichen vitaminen bei postmenopausalen frauen und in tieren

Country Status (21)

Country Link
US (1) US6476010B2 (de)
EP (1) EP1261330B1 (de)
JP (3) JP5551326B2 (de)
KR (1) KR100788522B1 (de)
CN (1) CN1298319C (de)
AR (1) AR046234A1 (de)
AT (1) ATE336994T1 (de)
AU (2) AU2001249106B2 (de)
BR (1) BR0109148A (de)
CA (1) CA2402121C (de)
DE (1) DE60122477T2 (de)
DK (1) DK1261330T3 (de)
ES (1) ES2270995T3 (de)
HK (1) HK1054499A1 (de)
IL (1) IL151585A0 (de)
MX (1) MXPA02008766A (de)
MY (1) MY119973A (de)
NO (1) NO330566B1 (de)
NZ (1) NZ521159A (de)
TW (1) TWI301065B (de)
WO (1) WO2001068075A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2322328T3 (es) * 1999-09-03 2009-06-19 Sigma-Tau Healthscience S.P.A. L-carnitina ultrafina, procedimientos de preparacion, composiciones que la contienen y procedimiento de uso de la misma.
WO2003009840A1 (en) * 2001-07-24 2003-02-06 Lonza Ag Composition comprising at least one lipase inhibitor and carnitine
US20060083796A1 (en) * 2002-09-09 2006-04-20 Sylvie Pridmore-Merten Orally administrable composition for improving hair and coat quality
WO2004112767A1 (en) * 2003-06-19 2004-12-29 Advanced Bionutriton Corporation Improved absorption of fat-soluble nutrients
US20060204550A1 (en) * 2005-03-11 2006-09-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Food and beverages containing L-carnitine derivatives
US10398729B2 (en) * 2012-02-14 2019-09-03 Kenneth O. Russell Method for treating Alzheimer's disease
KR101168657B1 (ko) * 2010-06-01 2012-07-25 주식회사 셀트리온제약 아세틸-ｌ-카르니틴 말산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
FR3090347B1 (fr) * 2018-12-20 2020-12-18 Oreal Procédé de traitement des fibres kératiniques mettant en œuvre une composition comprenant un sel de carnitine ou de dérivé de carnitine comprenant un anion d’acide dicarboxylique aliphatique

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
US5030458A (en) 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
US4883672A (en) 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
US5223264A (en) 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5030657A (en) 1989-10-23 1991-07-09 University Of Georgia Research Foundation, Inc. L-carnitine supplemented catfish diet
EP0675725B1 (de) 1992-12-23 2002-01-30 Abbott Laboratories Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
US5700782A (en) 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5438042B1 (en) 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
EP0746209A1 (de) 1994-02-22 1996-12-11 Lonza Inc. Verbesserung des wachstums und der milcherzeugung von wiederkäufern
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5661123A (en) 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
IT1275434B (it) 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
US5560928A (en) 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
IT1299191B1 (it) 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
EP1104247B1 (de) 1998-06-26 2019-01-09 IAMS Europe B.V. Methode und produkt zur stimulierung von gewichtsverlust bei übergewichtigen hunden

Also Published As

Publication number Publication date
EP1261330A2 (de) 2002-12-04
KR100788522B1 (ko) 2007-12-24
MXPA02008766A (es) 2004-09-06
NO20024287D0 (no) 2002-09-09
NZ521159A (en) 2004-04-30
IL151585A0 (en) 2003-04-10
MY119973A (en) 2005-08-30
JP5551326B2 (ja) 2014-07-16
US20010041695A1 (en) 2001-11-15
TWI301065B (en) 2008-09-21
AU4910601A (en) 2001-09-24
BR0109148A (pt) 2003-04-22
AU2001249106B2 (en) 2005-07-07
AR046234A1 (es) 2005-11-30
KR20030007456A (ko) 2003-01-23
CN1298319C (zh) 2007-02-07
CA2402121C (en) 2009-09-22
JP2014148520A (ja) 2014-08-21
NO330566B1 (no) 2011-05-16
EP1261330B1 (de) 2006-08-23
CA2402121A1 (en) 2001-09-20
WO2001068075A2 (en) 2001-09-20
NO20024287L (no) 2002-11-01
WO2001068075A3 (en) 2002-04-18
HK1054499A1 (en) 2003-12-05
JP2012162537A (ja) 2012-08-30
ES2270995T3 (es) 2007-04-16
CN1429110A (zh) 2003-07-09
ATE336994T1 (de) 2006-09-15
JP2003526661A (ja) 2003-09-09
US6476010B2 (en) 2002-11-05
DE60122477T2 (de) 2007-05-24
DK1261330T3 (da) 2006-12-11

Similar Documents

Publication Publication Date Title
DE10195721T1 (de) Teilwert-Spielsystem und Spielverfahren
DE60134977D1 (de) Verfahren und vorrichtung zur herstellung von absorbierenden artikeln mit wiederverschliessbaren nahtstellen
DE19882669T1 (de) Vorrichtung und Verfahren zur Pflege der Ferse
DE60231723D1 (de) Verfahren und vorrichtung zur herstellung von wiederverschliessbaren absorbierenden artikeln
DE60139256D1 (de) Verfahren und vorrichtung zur herstellung von flüssigen verabreichungsformen
DE59912579D1 (de) Verfahren und Vorrichtung zur Herstellung von Packungen
NO20025507D0 (no) Brönnreferanseapparat samt fremgangsmÕte
DE60105884D1 (de) Mittel und Verfahren zum Verformen von Weichgewebe
DE60236630D1 (de) Verfahren und zugehörendes Gerät zur verteilten dynamischen Funkrufzonengruppierung in heterogenen Zugangsnetzen
DE69917477D1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
DE60018842D1 (de) Stereolithografisches Verfahren und Vorrichtung
DE69823540D1 (de) Sterilisationsverpackung und verfahren
DE60012167D1 (de) Vorrichtung und verfahren zum warmhalten von speisen
DE60020571D1 (de) Verfahren und vorrichtung zur unterscheidung und zählung von leukozyten
DE69815328D1 (de) Verfahren und enzymhaltige formulierung zum abbau von speiseresten
DE69824315D1 (de) Verfahren zur charakterisierung komplexer flüssigkeiten und vorrichtungen zur durchführung des verfahrens
DE60122477D1 (de) Verfahren zur erhöhung der darmabsorption von fettlöslichen vitaminen bei postmenopausalen frauen und in tieren
DE69807021D1 (de) Verfahren und Geraet zur Implementierung von mehrfachen Ruecksprungstellen
DE69907826D1 (de) Verfahren und vorrichtung zum verbinden von coextrudierten nahrungsmitteln
DE69913476D1 (de) Polierverfahren und vorrichtung
DE60110971D1 (de) Zerstäubungsvorrichtung und Verfahren
DE69828532D1 (de) Verfahren und vorrichtung zum fördern von lasten
ATE382887T1 (de) Verfahren und system zur verzögerungszeitreduktion in der packungsindustrie
DE60102198D1 (de) Bremsverfahren in einem integrierten Zugantrieb- und Bremssystem
DE69903534D1 (de) Kegelspielvorrichtung und verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition